Impact of Low Bone Mineral Content Index on Cardiovascular Outcomes in Patients With Coronary Artery Disease

Tadashi Itagaki1, Yasushi Ueki2, Daisuke Sunohara2

  • 1Department of Cardiology, Nagano Municipal Hospital, Japan.

Angiology
|January 4, 2024
PubMed

Insights

Low bone mineral content index (BMCI) is a significant predictor of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). This finding highlights BMCI as a potential prognostic marker for cardiovascular outcomes.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Clinical Outcomes Research

Background:

  • The prognostic significance of bone mineral content (BMC) in patients with coronary artery disease (CAD) is not well-established.
  • Assessing BMC may offer new insights into cardiovascular risk stratification.

Purpose of the Study:

  • To investigate the association between the bone mineral content index (BMCI) and major adverse cardiovascular events (MACE) in patients with CAD undergoing percutaneous coronary intervention (PCI).

Main Methods:

  • A cohort of 257 CAD patients undergoing PCI were analyzed between January 2020 and June 2021.
  • BMCI was calculated using bioelectrical impedance analysis (BMC/height squared).
  • Patients were stratified into low (<0.918) and high (≥0.918) BMCI groups based on receiver operating characteristic curve analysis for MACE.

Main Results:

  • During a median follow-up of 744 days, the low BMCI group (n=152) exhibited a significantly higher incidence of MACE (19.7%) compared to the high BMCI group (n=105, 6.7%; P=.004).
  • Multivariable Cox and Inverse Probability of Treatment Weighting analyses confirmed that low BMCI was a significant predictor of MACE (Hazard Ratio: 3.16; 95% Confidence Interval: 1.15-8.67; P=.025).

Conclusions:

  • The bone mineral content index (BMCI) serves as a valuable predictor of cardiovascular events in patients with coronary artery disease undergoing PCI.
  • Further investigation is warranted to explore therapeutic strategies targeting BMC to potentially enhance patient prognosis.